by Henrianne DE PONTBRIAND | 6 Feb, 2018 | Bioethics press synthesis
In the United States, the FDA has approved “the very first algorithm to monitor vital signs in patients in order to predict potentially fatal events a few hours before they occur”. Developed by the ExcelMedical Company, this form of “artificial...
by Henrianne DE PONTBRIAND | 6 Feb, 2018 | Bioethics press synthesis | MAP – Surrogacy
For clinicians Geneviève Delaisi de Parseval and Stéphane Viville, although genetic testing has already put an end to guaranteed gamete donor anonymity, “structured, welcome access to origins must be arranged”. Without overlooking the need for a...
by Henrianne DE PONTBRIAND | 6 Feb, 2018 | Bioethics press synthesis | End of life
A European study has highlighted variations in the practices of resuscitation and intensive care units, particularly with regard to admission, discharge and treatment procedures for the very elderly. Using a questionnaire, researchers have recorded the opinions of...
by Henrianne DE PONTBRIAND | 6 Feb, 2018 | Bioethics press synthesis | MAP – Surrogacy
Just days after the launch of États Généraux (Estates General) on Bioethics, Marianne Durano, Philosophy Graduate and author of Mon corps ne vous appartient pas (My body doesn’t belong to you), published an article in Le Figaro in which she denounced the...
by Henrianne DE PONTBRIAND | 6 Feb, 2018 | Bioethics press synthesis | Genome
Whereas the first human gene therapy clinical trial involving CRISPR-Cas9 is about to begin in the United States[1], the Wall Street Journal has reported that, in China, “at least 86 individuals” have already taken part in gene-editing experiments. Eleven...
by Henrianne DE PONTBRIAND | 6 Feb, 2018 | Bioethics press synthesis | Organ donation
The patient underwent face transplant surgery six years ago. In November, “the severity of the rejection” became chronic with necrotic plaque formation, and doctors were obliged to remove the transplant as his life was in jeopardy. Since then the man has...